Association of Blue Light-Filtering Intraocular Lenses With All-Cause and Traffic Accident-Related Injuries Among Patients Undergoing Bilateral Cataract Surgery in Finland.
Journal
JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235
Informations de publication
Date de publication:
01 08 2022
01 08 2022
Historique:
entrez:
17
8
2022
pubmed:
18
8
2022
medline:
20
8
2022
Statut:
epublish
Résumé
Blue light-filtering (BLF) intraocular lenses (IOLs) have been widely used in clinical practice for more than 20 years and have been implanted in millions of patients with cataracts worldwide. However, little evidence on the association of BLF IOLs with injuries is available. To assess the association of BLF IOLs with all-cause and traffic accident-related injuries and quality of vision while driving after bilateral cataract surgery. This retrospective registry-based cohort study included patients who underwent bilateral cataract surgery between September 3, 2007, and December 14, 2018, and were followed until December 14, 2021. Surgery was performed at the Department of Ophthalmology, Kymenlaakso Central Hospital, Kotka, Finland. The 4986 participants received non-BLF IOLs (n = 2609) or BLF IOLs (n = 2377) in both eyes. Patients undergoing bilateral surgery between 2015 to 2016 with non-BLF IOLs (n = 102) or BLF IOLs (n = 91) and currently driving a car were interviewed using a structured questionnaire for visual performance while driving. Follow-up for a mean (SD) of 2166 (1110) days after second eye surgery. Kaplan-Meier and multivariable Cox proportional hazards regression analyses for the risk of all-cause and traffic accident-related injuries after surgery in the second eye obtained from the patient medical records were assessed. To improve follow-up precision, both death and the end of the follow-up were used as censoring events. A total of 4986 patients were included in the analysis (1707 [34.2%] men and 3279 [65.8%] women; mean [SD] age, 73.2 [8.6] years at the first surgery and 74.3 [8.8] years at the second). Injury-free survival rates preceding the first eye surgery were comparable between the non-BLF and BLF IOL groups (hazard ratio adjusted for age and sex, 0.95 [95% CI, 0.81-1.13; P = .57]). In multivariable Cox proportional hazards regression analysis controlling for age and sex, the use of BLF IOLs showed no advantage in overall injuries compared with the use of non-BLF IOLs (hazard ratio, 0.99 [95% CI, 0.88-1.11]; P = .85) or in any injury subtype. Subjective visual performance parameters for driving were all comparable between the non-BLF and BLF IOL groups except for glare when driving in the dark (evening or night), which occurred among 9 of 80 patients with BLF IOLs compared with 0 of 83 non-BLF IOLs (P < .001). The findings of this cohort study suggest that use of BLF IOLs was not associated with reduced risk of injuries, whereas glare during nighttime driving was significantly worse in the BLF IOL group with pseudophakia.
Identifiants
pubmed: 35976646
pii: 2795247
doi: 10.1001/jamanetworkopen.2022.27232
pmc: PMC9386539
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2227232Références
Age Ageing. 2006 Jan;35(1):66-71
pubmed: 16364936
JAMA Ophthalmol. 2019 Oct 01;137(10):1147-1153
pubmed: 31369054
Vision Res. 1999 Nov;39(22):3728-36
pubmed: 10746143
Health Serv Res. 2005 Oct;40(5 Pt 2):1620-39
pubmed: 16178999
Hum Factors. 1981 Feb;23(1):59-64
pubmed: 7228047
Ophthalmology. 2009 Jan;116(1):39-45
pubmed: 19118695
Invest Ophthalmol Vis Sci. 2001 Feb;42(2):497-505
pubmed: 11157889
J Cataract Refract Surg. 2011 Jan;37(1):38-44
pubmed: 21183098
Free Radic Biol Med. 1997;22(7):1229-34
pubmed: 9098097
J Cataract Refract Surg. 2005 Oct;31(10):1952-9
pubmed: 16338566
Am J Ophthalmol. 2004 Jul;138(1):138-40
pubmed: 15234295
Int Ophthalmol. 2016 Jun;36(3):313-8
pubmed: 26286756
Acta Ophthalmol. 2020 Jun;98(4):e495-e498
pubmed: 31654472
Invest Ophthalmol Vis Sci. 2012 Jun 26;53(7):4076-84
pubmed: 22491402
Graefes Arch Clin Exp Ophthalmol. 2019 Jun;257(6):1091-1099
pubmed: 30824995
Curr Eye Res. 1992 Sep;11(9):825-31
pubmed: 1330441
Gerontology. 1991;37(4):221-4
pubmed: 1916313
Ann Transl Med. 2020 Nov;8(22):1543
pubmed: 33313288
Br J Ophthalmol. 2006 Jun;90(6):784-92
pubmed: 16714268
Am J Ophthalmol. 2012 Apr;153(4):587-93
pubmed: 22445628
Surv Ophthalmol. 2010 May-Jun;55(3):272-89
pubmed: 19883931
J Cataract Refract Surg. 2017 Aug;43(8):1077-1080
pubmed: 28917410
J Cataract Refract Surg. 2010 Jan;36(1):13-9
pubmed: 20117700
Ophthalmology. 2011 Jan;118(1):1-2
pubmed: 21199710
J Cataract Refract Surg. 2006 Jan;32(1):141-4
pubmed: 16516793
Br J Ophthalmol. 2005 Jan;89(1):53-9
pubmed: 15615747
Vision Res. 1997 Feb;37(4):475-81
pubmed: 9156178
Clin Ophthalmol. 2010 Dec 08;4:1465-73
pubmed: 21191442
J Cataract Refract Surg. 2005 Sep;31(9):1736-40
pubmed: 16246777
Vision Res. 1999 Nov;39(23):3975-82
pubmed: 10748929
Curr Opin Ophthalmol. 2011 Jan;22(1):19-27
pubmed: 21088580
Arch Ophthalmol. 2005 Apr;123(4):550-5
pubmed: 15824232